Share on StockTwits
 

Nutrisystem (NASDAQ:NTRI) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research report issued on Friday, Analyst RN reports. They currently have a $18.80 price target on the stock. Zacks‘ price objective indicates a potential upside of 18.84% from the company’s current price.

Several other analysts have also recently commented on the stock. Analysts at Janney Montgomery Scott raised their price target on shares of Nutrisystem from $15.00 to $16.00 in a research note to investors on Friday, November 15th. They now have a “neutral” rating on the stock. Separately, analysts at Midtown Partners downgraded shares of Nutrisystem from a “neutral” rating to a “sell” rating in a research note to investors on Tuesday, November 5th. They now have a $17.57 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Thomson Reuters/Verus downgraded shares of Nutrisystem from a “buy” rating to a “hold” rating in a research note to investors on Monday, November 4th. One research analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $16.56.

Shares of Nutrisystem (NASDAQ:NTRI) traded down 2.15% during mid-day trading on Friday, hitting $15.48. 321,495 shares of the company’s stock traded hands. Nutrisystem has a one year low of $7.18 and a one year high of $20.54. The stock has a 50-day moving average of $16.99 and a 200-day moving average of $15.21. The company has a market cap of $433.3 million and a price-to-earnings ratio of 385.85.

Nutrisystem, Inc (NASDAQ:NTRI) is a provider of a weight management system.

To view Zacks’ full report, visit www.zacks.com

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.